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Abstract
Vaginal candidiasis is a common disorder in women of childbearing age, caused primarily
by the dimorphic fungus Candida albicans. Since C. albicans is a normal commensal of the
vaginal mucosa, a long-standing question is how the fungus switches from being a harm-
less commensal to a virulent pathogen. Work with human subjects and in mouse disease
models suggests that host inflammatory processes drive the onset of symptomatic infec-
tion. Fungal cell wall molecules can induce inflammation through activation of epithelial and
immune receptors that trigger pro-inflammatory cytokines and chemokines, but pathogenic
fungi can evade recognition by masking these molecules. Knowledge about which cell wall
epitopes are available for immune recognition during human infection could implicate spe-
cific ligands and receptors in the symptoms of vaginal candidiasis. To address this impor-
tant gap, we directly probed the surface of fungi present in fresh vaginal samples obtained
both from women with symptomatic Candida vaginitis and from women that are colonized
but asymptomatic. We find that the pro-inflammatory cell wall polysaccharide β-glucan is
largely masked from immune recognition, especially on yeast. It is only exposed on a small
percentage of hyphal cells, where it tends to co-localize with enhanced levels of chitin.
Enhanced β-glucan availability is only found in symptomatic patients with strong neutrophil
infiltration, implicating neutrophils as a possible driver of these cell wall changes. This is
especially interesting because neutrophils were recently shown to be necessary and suffi-
cient to provoke enhanced β-glucan exposure in C. albicans, accompanied by elevated
immune responses. Taken together, our data suggest that the architecture of C. albicans
cell wall can be altered by environmental stress during vaginal candidiasis.
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Introduction
C. albicans causes both mucosal and disseminated disease, but vaginitis is the only disease it causes
in healthy adults [1]. Acute vulvovaginal candidiasis (VVC) is estimated to affect two-thirds of all
women during their lifetimes, while recurrent VVC (RVVC) is more severe but less common.
Unfortunately, we still know little about why some women suffer from VVC or RVVC and
others do not [2–5]. Both VVC and RVVC are usually caused by C. albicans, but can be caused
by C. glabrata, C. krusei, and many other species [2, 4]. Therapy for VVC relies on a variety of
azoles, which are of limited use due to concerns about the use of fluconazole in pregnancy [6–8].
Vaginitis symptoms from C. albicans infection are thought to stem from host immune
responses rather than pathogen-mediated damage [9]. Support for this idea comes from a
unique human challenge study that found that neutrophilic inflammation, rather than fungal
burden, was the greatest predictor of symptomatic infection in otherwise healthy women [10].
Host inflammatory processes can be triggered by fungal cell wall molecules and proteins that
interact with receptors of innate immune and epithelial cells [11–15]. Despite their well-recog-
nized capacity to stimulate inflammation, we still understand little about the fungal cell wall
ligands that are actually available for immune recognition during vaginal infection, especially
during human infection.
Pattern recognition of fungal cell wall components is limited by pathogens that regulate the
availability of specific epitopes for interaction with immune receptors [16, 17]. C. albicans and
other fungi can mask cell wall β-glucan and chitin from recognition by Dectin-1 and other
PRRs, but it is unknown if this mechanism of evasion is used in human infection [16]. Some in
vivo and in vitro models suggest that β-glucan is largely masked [18, 19], but other in vitro
experiments have documented some β-glucan exposure during epithelial infection [20]. These
differences among models may arise because each model presents a unique subset of signals
that regulate exposure of cell wall epitopes, including environmental cues, stresses, and
immune-triggered cell wall remodeling [17]. This is especially intriguing for VVC, where in
vitro-validated cues for masking (lactate) and unmasking (low pH) are both expected to be
present [21, 22]. It is difficult to exactly replicate the environmental conditions during human
infection in vitro, especially because they are likely to be dynamic and to depend on infection
progression in individual patients.
Clinical studies of epitope exposure are technically and logistically challenging because
epitope exposure is sensitive to fixation conditions and is ideally studied in directly-obtained
samples. Nevertheless, such work could reveal important information about host-pathogen
interaction during human disease and point to which experimental model(s) would be best for
the study of epitope recognition during infection. We have addressed the technical issues asso-
ciated with such a clinical study by probing the surface of C. albicans that was freshly isolated
from vaginitis patients. In this first study of epitope exposure in human infection, we find only
rare sites of β-glucan exposure on hyphal cells. These cases of β-glucan unmasking are often
associated with chitin deposition, are found only in the presence of strong neutrophilic infil-
trates, and correlate with evidence of neutrophil extracellular traps. These data suggest both
that C. albicans masks cell wall components from immune recognition in vivo and that neutro-
phils may drive some limited level of unmasking during human infection.
Materials and methods
Ethics statement
All women signed an informed consent in accordance with the Declaration of Helsinki. Local
Ethical Committee CEAS (Comitato Etico delle Aziende Sanitarie, Umbria, Italy) approval
was received for the whole study (VAG1 n. 2652/15) on February 1, 2016.
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Subjects
Thirty Candida-positive non-diabetic women, 19 to 53 years old, attending the microbiological
diagnostic service of the University Hospital Santa Maria della Misericordia, Perugia (Italy)
over the period from February 2016 to April 2017 were consecutively enrolled in this study.
Enrollment and consent was done as described [23]. This included both those who attended
for both routine screening and those with symptoms of vaginal disease. Prior to enrollment,
each subject answered a questionnaire indicating their health status and current symptoms of
vaginal disease. None of the patients was taking any treatments for symptoms at the time of
enrollment. A case of VVC due to Candida was defined as the presence of at least two of the
following signs and symptoms: vaginal discharge, itching, burning, dyspareunia, and Candida
isolation from the vaginal sample. None of the recruited women had RVVC, as indicated by
the absence of documented or subject-reported, repeated VVC episodes per year. All women
signed an informed consent in accordance with the Declaration of Helsinki. Local Ethical
Committee CEAS (Comitato Etico delle Aziende Sanitarie, Umbria, Italy) approval was
received for the whole study (VAG1 n. 2652/15).
Neutrophil infiltration scoring, pH analysis and bacterial identification
Vaginal swabs were taken and soaked in 1 ml of saline, as described in [23]. To measure pH,
a vaginal swab was taken from each participant and soaked in 1 ml of saline. The pH was
measured by pH-Fix strips (Macherey-Nagel GmbH & Co. KG, Germany). The morphotypic
evaluation of vaginal microbiota was performed by the observation of a fresh preparation of
vaginal fluid or by Gram staining method under the light microscope. In particular, the pres-
ence or absence of Lactobacilli was verified. After sampling, the vaginal swab was plated on
Tryptic Soy Agar II with 5% sheep blood or on Gardnerella Selective Agar with 5% human
blood or on Columbia Agar with 5% Sheep Blood (all from Becton Dickinson) to test the vag-
inal colonization by Lactobacilli, G. vaginalis or S. agalactiae (Group B Streptococcal or
GBS), respectively. Samples were examined under light microscope (Olympus, Milan, Italy)
to evaluate the presence of neutrophils (PMN) by their morphology after staining with Papa-
nicolaou technique, as described in [10, 23]. The number of PMN was counted in four fields
at x400 magnification and expressed as average number of PMN/field. The PMN score was
graded on a scale from 0 to 2: 0, 0 PMN/field; 1, 1 to 10 PMN/field; 2, 11 to 40 PMN/field as
previously described [23]. This gradation allowed for semi-quantitative analysis of neutro-
phil numbers while limiting burden on attending physicians. Candida-positive vaginal sam-
ples were categorized as: no or low neutrophil infiltration (LI; score 1) or high neutrophil
infiltration (HI; score = 2). This cohort included women who were C. albicans-positive with
high neutrophil infiltration (HI; n = 15), C. albicans-positive with low-no neutrophil infiltra-
tion (LI; n = 7), non-albicans Candida (NAC) with high neutrophil infiltration (HI; n = 2),
and NAC with no or low neutrophil infiltration (LI; n = 6). pH was measured in vaginal
samples.
Sample collection and species identification
A separate vaginal swab was taken from each subject and soaked in 2 ml of PBS. After sam-
pling, the vaginal swab was plated on CHROMagar™ Candida (VWR International p.b.i.,
Milan, Italy) at 37˚C for 48 hours to evaluate the vaginal colonization by C. albicans. The pres-
ence of C. albicans was confirmed by MALDI-TOF using the VITEK MS system (Biome´rieux
S.A. France). Subsequently, the vaginal fluid was centrifuged at 3,000 x rcf for 5 min. The cellu-
lar fraction in the pellet was resuspended and half was used for live staining.
Fungal epitope unmasking in human vaginitis
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Live staining of the cellular fraction of vaginal swabs
Vaginal swabs were processed within 5 hours (hr) of collection, without fixation, similar to
processing for ex vivo fluorescence [24]. Previous work suggests that fixation can alter cell sur-
face characteristics (Wheeler et al. 2006), so this was avoided at all costs. Initial tests of staining
C. albicans from vaginal swabs after 1 hr, 5 hr, and 18 hr post-collection, with storage at room
temperature in saline, showed no differences in staining levels. However, to limit any artifacts
of storage, the stainings were all performed within 5 hr of collection. The cellular fraction of
the vaginal swab was washed three times in phosphate buffered saline (PBS), with a 15-second
spin at maximum speed (15,000 x rcf) in the microcentrifuge (Eppendorf 5415C), decanting of
the supernatant, resuspension of the pellet in the residual volume, then addition of 500 μl of
ice-cold PBS. Following the initial wash steps and prior to adding the staining reagents, cells
were resuspended in 100 μl of PBS + 1% BSA by flicking the pellet, 1 x 106 KAH3-EGFP cells
was added as a positive internal control, and the sample was briefly incubated on ice for 5 min-
utes to block non-specific staining. Once washed and blocked, staining reagents were added:
sDectin-1-Fc (1.25:100 from 1.4 μg/microliter), Calcofluor white (5:100 from 100 μg /ml stock)
and Sytox Green (0.25:100 from 5 mM stock). The sDectin-1-Fc was purified from HEK293T
cells as described [25] then labeled directly with Alexafluor 555. To directly label the sDectin-
1-Fc, 220 micrograms of purified protein (100 μl in PBS + 45% glycerol) was mixed with
100 μg of Alexafluor 555-succinimidyl ester (lyophilized; Thermo Fisher) and 10 μl of 1 M
NaCO3 for a final pH of 8.5, incubated at room temperature for one hour, run through a gel fil-
tration spin column pre-equilibrated with PBS (G-25, GE Healthcare), and then adjusted to
45% glycerol in PBS. Calcofluor white (Fluorescent Brightener 28 F3543; Sigma-Aldrich) was
dissolved in water. Sytox Green (Thermo Fisher) was dissolved in dimethylsulfoxide. The
KAH3-EGFP strain can be distinguished from yeast in the vaginal swab sample because it
expresses cytoplasmic EGFP, and it has previously been described to have enhanced β-glucan
exposure and sDectin-1 staining [19]. Then, the staining reagents were added, and the cells
were further incubated for 30 minutes on ice. Cells were then washed three times in one milli-
liter of PBS as above and were resuspended in 50 μl. Ten μl of sample were spread in a line on
a microscope slide and covered with a #1 coverslip (24 mm x 60 mm) for imaging.
Microscopic analysis
Samples were imaged with a Zeiss Axiobserver Z1 microscope and Axiocam MRm camera
using DAPI, FITC, and Rhodamine filter sets, using a Plan Neofluor 40x 0.75 N.A. air objective
and Zeiss Axiovision software. Z-stacks were processed in ImageJ by creating maximum pro-
jections and then scored as follows. There were rare broken C. albicans filaments (<3% of the
total) that were excluded from analysis because it was not known if the breakage was due to
immune activity during infection response or due to the shear stress associated with resus-
pending the cell pellet during staining. sDectin-1-positive cells and hyphal segments were
identified based on having staining above background. Counts were pooled for all fields
imaged of a given sample. Morphology was scored by counting all elongated cells as part of fil-
aments, either pseudohyphae or hyphae, using Calcofluor white staining to identify septae and
thus filament segments. Counts were pooled for all fields imaged of a given sample. A field
with any extracellular, diffuse Sytox Green staining was scored as positive for eDNA, and the
percentage of all imaged fields with any eDNA was calculated. Maximum projections of repre-
sentative images were further processed, with equal adjustments for all images, in Photoshop
and Illustrator to add notations and scalebars. Where noted, images were enhanced to empha-
size a specific finding, such as the extremely weak but noticeable sDectin-1 staining of bud
scars on yeast shown in the inset for Fig 1.
Fungal epitope unmasking in human vaginitis
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Fig 1. Enhanced Dectin-1 recognition is filament-specific and co-localizes with enhanced chitin deposition. Vaginal swab
samples were stained with sDectin-1-Fc (sDectin-1; red), Calcofluor white (CFW; blue; outline of fungi for morphology and for
identification of sites of increased chitin deposition), and Sytox Green (green; stains only extracellular DNA and DNA inside
cells with compromised membranes). The EGFP-expressing strain KAH3-EGFP was spiked in before staining as a positive
control. Several 40x fields (8–16 per sample) were imaged and scored for fungal morphology, sites of sDectin-1 staining, co-
localization of sDectin-1 staining and increased CFW staining, and presence of extracellular DNA. (A) In samples from C.
albicans-infected patients, only filaments were found with enhanced sDectin-1 staining. (B) In samples from patients infected
with non-albicans Candida or a mix of C. albicans and non-albicans Candida, only filaments were stained with sDectin-1. The
only sample with any sDectin-1+ cells was a mix of C. albicans and C. norvegensis (Sample #SP-97366). The difference in
frequency of staining is not significantly different between filaments and yeast (p >0.9999), because there was virtually no
staining of either morphology. (C) Representative field from C. albicans-infection sample (#SP-66117). A single filament segment
that is swollen (purple arrow) has high levels of sDectin-1 and CFW staining. The top image is a three-color overlay and the
Fungal epitope unmasking in human vaginitis
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Statistical analysis
All statistics were performed in Graphpad 6 (Prism). Mann-Whitney and Spearman correla-
tion tests were used as non-parametric tests, as indicated in Figure Legends. Significance
throughout the figures is indicated with: n.s. p > 0.05;  p< 0.05;  p< 0.01;  p< 0.001;
 p< 0.0001.
Results
The innate immune system recognizes C. albicans through pattern recognition receptors that
are triggered by cell wall molecules that include β-glucan [12]. C. albicans and other fungi are
able to avoid recognition by reducing β-glucan availability, although it is not yet understood if
any fungus evades β-glucan detection during human infection [24]. We sought to measure β-
glucan exposure in fungi during vulvovaginal infection. We recruited patients from the micro-
biological diagnostic service of the University Hospital Santa Maria della Misericordia, includ-
ing both patients that came to the clinic complaining of vaginitis and pregnant women coming
for routine screening. Vaginal lavages were screened for the presence of fungi and scored for
levels of neutrophilic infiltrate (HI or LI) as previously detailed [23].
Samples with fungi were processed for microbiological identification and measurement of
fungal epitope exposure. Identification was made by the complementary methods of MALDI-
TOF and Chromagar growth. In most cases (29/30), results were congruent. In one case (#SP-
97366), more than one type of colony was identified on Chromagar, and these colonies were
subsequently processed for identification by MALDI-TOF, which confirmed the Chromagar
identification. The majority of cases were due to C. albicans (22/30), with occasional infection
by C. glabrata (3/30), C. krusei (2/30) and others (Table 1).
Epitope exposure was measured using an ex vivo fluorescence protocol modified from that
used for probing live fungi isolated directly from infected mouse organs [24]. In this fluores-
cence microscopy assay, we used soluble Dectin-1-Fc (sDectin-1) to monitor β-glucan expo-
sure, the chitin-staining dye Calcofluor white (CFW) to monitor chitin deposition and fungal
morphology, and the membrane-impermeable dye Sytox Green to identify dead fungi and
stain extracellular DNA. We note that CFW staining is a good quantitative measure of chitin
levels in C. albicans [26], but has been shown to bind to other polysaccharides such as cellulose
that have not been found in C. albicans cell walls [27]. Due to the low overall frequency of
sDectin-1-positive cells, an EGFP-expressing mutant of C. albicans (KAH3) with moderate lev-
els of β-glucan exposure [18] was spiked in as a positive control to ensure even staining from
sample to sample (S1 Fig).
Only a small proportion of live fungi from vaginal lavages stained strongly with sDectin-1,
and this varied significantly from patient to patient (Table 1, Fig 1A). For C. albicans, sDectin-
1 staining was seen exclusively in hyphal and pseudo-hyphal filaments, and only a small per-
centage of those cells (Fig 1A and 1C). No high-level sDectin-1 staining was seen in other spe-
cies, including C. glabrata and C. krusei, although very weak sDectin-1 staining was seen
occasionally in these yeast at bud scars, as has been previously reported (Fig 1B and 1D & D-
images below separate the sDectin-1 and CFW. (D) Representative field from a non-albicans Candida infection sample (#SP-
12622). Most of the fungi are yeast from the infected patient without high levels of sDectin-1 or CFW staining (white arrows). In
the upper right is a cluster of cells from the spiked-in control KAH3-EGFP (white arrowheads) with enhanced sDectin-1 and
CFW staining. The CFW is overexposed to visualize the weakly-staining C. krusei cells from the patient, but the cell outlines can
be clearly seen in the sDectin-1 staining image in red. (E) Schematic to illustrate that the majority of sites (58%) with enhanced
sDectin-1 staining also had increased chitin deposition. Images are maximum projections of 6 slices (J) or 5 slices (K).
Scalebar = 20 μm throughout. Statistics used for (H) and (I) were Mann-Whitney non-parametric tests. Significance throughout
the figure is indicated with: n.s. p> 0.05;  p< 0.05;  p< 0.01;  p< 0.001;  p< 0.0001.
https://doi.org/10.1371/journal.pone.0201436.g001
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inset; [18, 28]). Note that the contrast on these inset images had to be extremely enhanced to
bring out even this faint staining. Nearly all of the sites of sDectin-1 reactivity in live cells were
in the lateral wall of filaments, and the Dectin-1-positive cell segments were often swollen.
Interestingly, the majority of Dectin-1-positive sites had elevated levels of CFW staining (Fig
1C–1E and S1 Fig). Some dead fungal cells had high labeling with sDectin-1 at the ends of bro-
ken filaments that may have been broken during the collection and staining procedure (S2
Fig). Overall, sDectin-1 reactivity was infrequent, was only seen in C. albicans hyphae, and was
associated with increased CFW staining that suggests high chitin deposition.
Because co-localization of enhanced sDectin-1 reactivity and chitin deposition can be trig-
gered by neutrophil-mediated damage of C. albicans hyphae [24], we suspected that these
Table 1. Staining with sDectin-1 on hyphae is associated with neutrophil infiltration and extracellular DNA.
Neutrophil
Infiltration
Patient # Fungal species % Hyphae % sDectin-1-positive
(Hyphal)
% sDectin-1-positive
(yeast)
% Fields with Extracellular
DNA
High SP-14248 C. albicans 67.3 6.35 0 100
SP-12635 C. albicans 53.7 0.27 0 100
SP-12522 C. albicans 82.7 7.2 0 100
SP-11266 C. albicans 32.7 1.4 0 100
SP-01417 C. albicans 88.1 5 0 57.1
SP-97296 C. albicans 64.4 3.3 0 100
SP-17001 C. albicans 0 0 0 14.2
SP-94976 C. albicans 48.6 5.7 0 100
SP-15980 C. albicans 66.3 21.7 0 100
SP-00703 C. albicans 76.4 8.4 0 100
SP-99758 C. albicans 73.2 10.3 0 100
SP-01887 C. albicans 83.7 4.4 0 100
SP-63354 C. albicans 86.4 17.3 0 100
SP-50711 C. albicans 22.4 10.1 0 100
SP-66117 C. albicans 31.4 9.3 0 100
Low or None SP-18387 C. albicans 22.5 0 0 100
SP-15231 C. albicans 9.5 0 0 100
SP-14314 C. albicans 1.2 0 0 12.5
SP-12753 C. albicans 23 0 0 14.2
SP-00503 C. albicans 0 0 0 42.8
SP-16884 C. albicans 11.9 0 0 85.7
SP-16850 C. albicans 27.8 0 0 0
High SP-12622 C. krusei 0 0 0 83.3
SP-
97366&
C. albicans/ C.
norvegensis
81.3 3.3 0 83.3
Low or None SP-11225 C. glabrata 0 0 0 0
SP-13835 C. glabrata 0 0 0 42.8
SP-15936 C. glabrata 0 0 0 33.3
SP-15949 C. krusei 0 0 0 22.2
SP-15194 C. guilliermondii 1.6 0 0 100
SP-90841 S. cerevisiae 0 0 0 0
Top samples are C. albicans only. Bottom set are mixed or only non-albicans Candida.
& Sample SP-97366 was mixed approximately 50–50 with C. norvegensis (identified by MALDI-TOF; white colonies on CHROMagar) and C. albicans (identified by
green colonies on CHROMagar). Based on known morphotypes of these species, it is likely that all the hyphae in this sample were C. albicans.
 Sample SP-15194 had filaments but these were only pseudohyphae.
https://doi.org/10.1371/journal.pone.0201436.t001
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phenotypes were caused by neutrophilic attack. To test for association between neutrophilic
attack and sDectin-1 recognition in VVC, we compared the prevalence of sDectin-1-staining
filament segments in patient samples depending on neutrophilic infiltration. Strikingly, β-glu-
can exposure was only found in samples from patients with high neutrophilic infiltration (Fig
2A). Neutrophil-triggered β-glucan exposure and chitin deposition in C. albicans filaments
can be blocked in vitro by eliminating neutrophil extracellular traps (NETs) that contain extra-
cellular DNA (eDNA; [24]). To test for a connection between eDNA and sDectin-1 staining,
we scored vaginitis samples from each patient for eDNA by staining with Sytox green; Dectin-
Fig 2. Neutrophil infiltration and extracellular DNA are closely associated with enhanced sDectin-1 staining. Vaginal swab samples with C.
albicans were scored by level of neutrophil infiltration, then stained and imaged as in Fig 1. (A) Samples with high levels of neutrophil
infiltration had sDectin-1-positive filaments, while those with low levels of infiltration had none. (B) Samples with high infiltration had a
significantly higher level of extracellular DNA (eDNA), as imaged using Sytox Green. (C) Samples with high levels of eDNA also had high
percentages of sDectin-1-positive cells. Samples with eDNA in every field were categorized as High eDNA, samples for which<100% of fields
had eDNA were categorized as Low eDNA. (D) Representative field of a sample (#SP-14314) with no fields containing eDNA, no hyphae, and
no sDectin-1-positive cells. Black arrowheads indicate nuclei from epithelial cells in the lavage. Image is maximum projection of 5 z-slices,
created by ImageJ. (E) Representative field of a sample (#SP-12522) with high levels of eDNA, hyphae, and sDectin-1 positive cells. Black
arrowheads indicate epithelial nuclei and white arrowheads indicate areas of diffuse Sytox Green staining of eDNA. Image is maximum
projection of 10 z-slices, created by ImageJ. Scalebar = 20 μm. Statistics used in (A-C) were Mann-Whitney non-parametric tests. Significance
throughout the figure is indicated with  p< 0.05,  p< 0.01,  p< 0.001.
https://doi.org/10.1371/journal.pone.0201436.g002
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1-labeled fungi were only found in those samples with high prevalence of extracellular DNA
(Fig 2B). Furthermore, there is a significantly higher frequency of sDectin-1-positive cells in
samples with high levels of eDNA (100% of fields with eDNA; Fig 2C). Representative images
illustrate both the stained nuclei of shed epithelial cells (Fig 2D) and the diffuse staining typi-
cally associated with extracellular traps (Fig 2E). Unfortunately, with the reagents we used it is
not possible to tell if there are bacterial organisms also associated with the eDNA. Although
these data are consistent with the presence of NETs, a more focused study would be required
to unambiguously identify these structures as NETs.
Vaginitis has been suggested to be associated with microbial dysbiosis, so vaginal swabs
were also scored clinically for the presence of Lactobacilli and other bacteria. Lactobacilli were
found in all samples, as has been seen before [29], suggesting that infection is not due to the
loss of these bacteria in our patient population (Table 2). Lactobacilli can reduce pH by pro-
ducing lactic acid, and elevated vaginal pH has been suggested to predispose for VVC, so pH
was measured in vaginal samples. As expected, we found that all measured samples had an
acidic pH range of 4–5, consistent with the ubiquitous presence of Lactobacilli in all patients
(Table 2). To further test a possible relationship between unmasking and low pH, we com-
pared the frequency of Dectin-1-positive cells in pH 4 vs. pH 5 samples and found no signifi-
cant correlation (Mann-Whitney; p = 0.3723).
Discussion
Interaction of Candida with host cells depends on the presence of host receptors and the avail-
ability of fungal ligands, but we know little about ligand exposure during human infection. In
this work, we found that β-glucan, a pro-inflammatory ligand for innate immune receptors, is
largely masked from recognition in fungi during acute vulvovaginal candidiasis in women.
However, strong neutrophil infiltration is associated with the presence of some hyphal C. albi-
cans cells with enhanced recognition by the Dectin-1 β-glucan receptor. These sites resemble
areas of cell wall remodeling that are found in vivo during murine invasive candidiasis and are
triggered by neutrophil attack on hyphae [24]. In contrast, infecting C. albicans yeast and non-
albicans Candida species without hyphae are not associated with strong neutrophilic infiltrates
and do not have localized areas of β-glucan exposure.
Previous in vivo and in vitro studies of C. albicans that have shown that environmental
stresses, drugs, and immune attack can all trigger cell wall remodeling that alters surface epi-
tope exposure and immune recognition [17, 30]. Consistent with these previous reports, our
clinical finding of a small but reproducible percentage of hyphal cells with enhanced epitope
exposure in the lateral cell wall suggests that C. albicans can and does actively remodel its cell
wall during infection. The strong correlation we found between conditions of high neutrophil
infiltration and the presence of sDectin-1-reactive hyphal segments suggests that neutrophils
may play a role in triggering cell wall remodeling events during human infection. Neutrophilic
infiltration correlated more strongly with VVC symptoms than fungal burden in an important
acute challenge study [10]. Consistent with this idea, mouse VVC models suggest that neutro-
phils are not particularly effective at limiting fungal burden but instead drive symptomatic
infection by enhancing inflammation [9, 31]. Taken in this context, the strong correlation of
neutrophil infiltration with unmasking we found may only reflect an indirect relationship
between neutrophil attack and unmasking. Alternatively, neutrophils may have reduced fungi-
cidal activity in the vagina during VVC, but still have enough activity to create extracellular
traps and trigger cell wall remodeling that enhances β-glucan exposure and Dectin-1 binding.
Moreover, given the role of inflammatory cytokines in neutrophil recruitment, greater β-
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glucan exposure could play a causative role in the high infiltration that is associated with β-glu-
can exposed hyphal segments [32–34].
The presence of cells with strong Dectin-1 binding suggests they might drive greater Dec-
tin-1-dependent inflammatory responses, as is the case in vitro [16]. However, this might not
be an important driver of human inflammatory responses in VVC, because Dectin-1 mutation
is not associated with altered susceptibility to RVVC [35]. Instead, Dectin-1 binding may indi-
cate areas of enhanced β-glucan exposure that lead to greater activation of the EphA2 receptor,
a newly described epithelial cell receptor for β-glucan [33]. There may also be altered exposure
of other cell wall polysaccharides such as chitin, which is also exposed at greater levels in the
context of β-glucan exposure [17]. If greater epitope exposure through neutrophilic attack
Table 2. Lactobacilli are found in most samples and are not associated with neutrophil infiltration or lack of sDectin-1+ cells.
Patient # Fungi Neutro sDectin-1+ Bacteria Lacto. G. vag. GBS Pregnant pH Sympto-matic?
SP-14248 C. a. High 6.35 + + - + N 4 Y
SP-12635 C. a. High 0.27 + - + + N n.a. Y
SP-12522 C. a. High 7.2 + + - - N 4 Y
SP-11266 C. a. High 1.4 + + - - N n.a. Y
SP-01417 C. a. High 5 + + - - N n.a. Y
SP-97296 C. a. High 3.3 + + - - N n.a. Y
SP-17001 C. a. High 0 + - + - Y 5 Y
SP-94976 C. a. High 5.7 + + - - Y n.a. Y
SP-15980 C. a. High 21.7 + + - + Y n.a. Y
SP-00703 C. a. High 8.4 + + + - Y 5 Y
SP-99758 C. a. High 10.3 + + - - Y 5 Y
SP-01887 C. a. High 4.4 + + - - Y 5 Y
SP-63354 C. a. High 17.3 + + - - Y n.a. Y
SP-50711 C. a. High 10.1 + + - - Y n.a. Y
SP-66117 C. a. High 9.3 + + - - Y n.a. Y
SP-18387 C. a. Low 0 + + - - N n.a. N
SP-15231 C. a. Low 0 + + - + N 4 N
SP-14314 C. a. Low 0 + + - - N 4 N
SP-12753 C. a. Low 0 + + - - N 5 N
SP-00503 C. a. Low 0 + + - - N n.a. N
SP-16884 C. a. Low 0 + + - - Y 4 N
SP-16850 C. a. Low 0 + + - + Y 4 N
SP-12622 C. k. High 0 + + - - N 4.5 Y
SP-97366 C. a./ C. n.& High 3.3 + + - - N 5 Y
SP-11225 C. gl. Low 0 + + - - N n.a. N
SP-13835 C. gl. Low 0 + + - - N 4 N
SP-15936 C. gl. Low 0 + + - - N 4 N
SP-15949 C. k. Low 0 + + - - N 5 N
SP-15194 C. guil. Low 0 + + - - N 5 N
SP-90841 S. c. Low 0 + - - + Y n.a. N
Top samples are C. albicans only. Bottom set are mixed or only non-albicans Candida.
& Sample SP-97366 was mixed with C. norvegensis (identified by MALDI-TOF) and C. albicans (identified by CHROMagar). Based on known morphotypes of these
species, it is likely that all the hyphae in this sample were C. albicans.
 Sample SP-15194 had filaments but these were only pseudohyphae. Abbreviations: C.a. (C. albicans), C.n. (C. norvegensis), C. gl. (C. glabrata), C. k. (C. krusei), C. guil
(C. guilliermondii), S. c. (Saccharomyces cerevisiae). n.a. = data not available for this sample.
https://doi.org/10.1371/journal.pone.0201436.t002
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leads to stronger inflammatory responses in vivo, it may be possible to limit VVC symptoms
by limiting epitope unmasking.
We found that, during colonization and active vaginitis, Candida yeast had extremely low
availability of β-glucan and only a small percentage of hyphal cells had strong β-glucan expo-
sure. Recent work in vitro suggests that two different environmental cues of the vaginal
milieu can signal changes in C. albicans epitope exposure and consequent immune stimula-
tion. On one hand, the presence of lactate enhances β-glucan masking and reduces immune
recognition [21]. On the other hand, acidic pH reduces β-glucan masking and increases
immune responses [22]. We found Lactobacilli in all patients and measured acidic pH for all
samples, suggesting the presence of lactate and low pH in the vaginal environment of all
patients. It should, however, be noted that due to practical limits of our approved IRB proto-
col, our technique for measuring pH was not the most precise method possible [36]. This is
in agreement with other studies that find no alteration in levels of lactic acid or pH in VVC
patients [37, 38]. Our finding of only a small percentage of C. albicans filament segments
with sDectin-1 reactivity suggests that the masking effects of lactate may dominate over the
effects of low pH in human VVC. However, it is possible that the strains differ significantly
from the clinical SC5314 strain, used in evaluation of the in vitro effects of nutritional or pH
alterations, in their basic cell wall composition or response to stresses. The masking we
observe in vivo is likely due to active fungal evasion, but there may be host molecules such as
natural anti-polysaccharide antibodies that contribute to masking [32, 39]. Further in vivo
studies focused on more precise measurement of pH, lactate and lactic acid in vaginal fluid,
combined with in vitro studies on a wider array of vaginal isolates, are likely to be more
conclusive.
Taken together with previous findings from in vitro and murine models, these data provide
the first indication that C. albicans immune evasion by epitope masking is not completely
effective during human infection. There are potential implications of this work for the treat-
ment of VVC. First, unmasked β-glucan may provoke stronger inflammatory responses
through direct binding to pro-inflammatory receptors and/or through activating complement
[32–34]. Recent work suggests that patients with high neutrophilic infiltrate also have high lev-
els of inflammatory cytokines associated with symptoms [23]. Thus, treatments that limit
unmasking may also reduce inflammation-associated symptoms. Interestingly, fluconazole is
effective in treatment of VVC and does not enhance β-glucan exposure in murine infection,
while echinocandins can unmask β-glucan and provoke greater inflammation [18]. Studies
of β-glucan exposure during treatment of patients could be informative about potential immu-
nomodulatory effects of antifungal therapy. Second, if environment-triggered unmasking
enhances inflammation, treatments targeting this process might effectively limit the symptoms
of vaginitis without affecting fungal burden. This lack of inflammatory activity may be an
important consideration as new therapeutics are developed against azole-resistant strains of
Candida.
Supporting information
S1 Fig. Example of the use of the spiked-in KAH3-EGFP strain to control for the staining
methodology. Vaginal swab samples were stained as described for Fig 1. In this field, there is
an example of a KAH3-EGFP cell (indicated with a white arrowhead) with a green cytoplasm
due to EGFP expression and high levels of chitin and sDectin-1 staining. There are also three
examples of filament segments that are sDectin-1+ (indicated with purple arrows). Each of
these sites also has enhanced levels of chitin staining, and one is a septum. Scalebar = 20 μm.
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Field is from sample #SP-12522, and is C. albicans. Image is maximum projection of 11 slices,
created by ImageJ.
(PDF)
S2 Fig. Examples of dead and broken filament segments with sDectin-1 staining. Vaginal
swab samples were stained as described for Fig 1. In many fields, there were broken ends of fil-
aments that were dead and excluded from analysis. In each of the two representative fields,
there is one filament segment that is broken and stained with sDectin-1 (indicated with a
white arrow). In panel A, the broken filament end only has sDectin-1 staining on the tip. In
panel B, the broken end has sDectin-1 staining descending from the end. Note that in neither
case is there enhanced chitin deposition in the cell wall with sDectin-1 staining. Scalebar =
20 μm. Fields are from sample #SP-15980, which is C. albicans. Image is maximum projection
of 10 z-slices, created by ImageJ.
(PDF)
Acknowledgments
The authors wish to thank Dr. Antonio Cassone and Dr. Paul Fidel for careful reading of the
manuscript.
Author Contributions
Conceptualization: Anna Vecchiarelli, Robert T. Wheeler.
Data curation: Eva Pericolini, Elena Gabrielli, Robert T. Wheeler.
Formal analysis: Eva Pericolini, Robert T. Wheeler.
Funding acquisition: Elisabetta Blasi, Robert T. Wheeler.
Investigation: Eva Pericolini, Stefano Perito, Anna Castagnoli, Elena Gabrielli, Robert T.
Wheeler.
Methodology: Stefano Perito, Robert T. Wheeler.
Resources: Stefano Perito, Antonella Mencacci.
Supervision: Antonella Mencacci, Elisabetta Blasi, Anna Vecchiarelli, Robert T. Wheeler.
Validation: Robert T. Wheeler.
Visualization: Robert T. Wheeler.
Writing – original draft: Eva Pericolini, Robert T. Wheeler.
Writing – review & editing: Eva Pericolini, Anna Vecchiarelli, Robert T. Wheeler.
References
1. Uppuluri P, Khan A, Edwards JE. Current Trends in Candidiasis. In: Prasad R, editor. Candida albicans:
Cellular and Molecular Biology. eBook: Springer International Publishing; 2017.
2. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010; 23(2):253–
73. https://doi.org/10.1128/CMR.00076-09 PMID: 20375352.
3. Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and suscep-
tibility to fluconazole in women. Am J Obstet Gynecol. 2002; 187(3):569–74. PMID: 12237629.
4. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
BJOG. 2015; 122(6):785–94. https://doi.org/10.1111/1471-0528.12994 PMID: 25052208.
5. Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016; 214(1):15–21. https://doi.
org/10.1016/j.ajog.2015.06.067 PMID: 26164695.
Fungal epitope unmasking in human vaginitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0201436 July 31, 2018 12 / 14
6. Eckert LO. Clinical practice. Acute vulvovaginitis. N Engl J Med. 2006; 355(12):1244–52. PMID:
16990387.
7. Molgaard-Nielsen D, Svanstrom H, Melbye M, Hviid A, Pasternak B. Association Between Use of Oral
Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016; 315
(1):58–67. https://doi.org/10.1001/jama.2015.17844 PMID: 26746458.
8. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance flucona-
zole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004; 351(9):876–83. https://doi.org/
10.1056/NEJMoa033114 PMID: 15329425.
9. Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr., et al. Candida albicans Patho-
genesis: Fitting within the Host-Microbe Damage Response Framework. Infect Immun. 2016; 84
(10):2724–39. https://doi.org/10.1128/IAI.00469-16 PMID: 27430274.
10. Fidel PL Jr., Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, et al. An intravaginal live Can-
dida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candi-
diasis. Infect Immun. 2004; 72(5):2939–46. https://doi.org/10.1128/IAI.72.5.2939-2946.2004 PMID:
15102806.
11. Gabrielli E, Sabbatini S, Roselletti E, Kasper L, Perito S, Hube B, et al. In vivo induction of neutrophil
chemotaxis by secretory aspartyl proteinases of Candida albicans. Virulence. 2016; 7(7):819–25.
https://doi.org/10.1080/21505594.2016.1184385 PMID: 27127904.
12. Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. Immune defence against
Candida fungal infections. Nat Rev Immunol. 2015; 15(10):630–42. https://doi.org/10.1038/nri3897
PMID: 26388329.
13. Peters BM, Yano J, Noverr MC, Fidel PL Jr.. Candida vaginitis: when opportunism knocks, the host
responds. PLoS Pathog. 2014; 10(4):e1003965. https://doi.org/10.1371/journal.ppat.1003965 PMID:
24699903.
14. Richardson JP, Willems HME, Moyes DL, Shoaie S, Barker KS, Tan SL, et al. Candidalysin drives epi-
thelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infect Immun.
2017. https://doi.org/10.1128/IAI.00645-17 PMID: 29109176.
15. Yano J, Palmer GE, Eberle KE, Peters BM, Vogl T, McKenzie AN, et al. Vaginal epithelial cell-derived
S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient
but not necessary for the acute neutrophil response during experimental vaginal candidiasis. Infect
Immun. 2014; 82(2):783–92. https://doi.org/10.1128/IAI.00861-13 PMID: 24478092.
16. Erwig LP, Gow NA. Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol. 2016; 14
(3):163–76. https://doi.org/10.1038/nrmicro.2015.21 PMID: 26853116.
17. Hopke A, Brown AJ, Hall RA, Wheeler RT. Dynamic fungal cell wall architecture in stress adaptation
and immune evasion. Trends in Microbiology. 2017;In press.
18. Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS
Pathog. 2006; 2(4):e35. https://doi.org/10.1371/journal.ppat.0020035 PMID: 16652171.
19. Wheeler RT, Kombe D, Agarwala SD, Fink GR. Dynamic, morphotype-specific Candida albicans beta-
glucan exposure during infection and drug treatment. PLoS Pathog. 2008; 4(12):e1000227. https://doi.
org/10.1371/journal.ppat.1000227 PMID: 19057660.
20. Villar CC, Dongari-Bagtzoglou A. Immune defence mechanisms and immunoenhancement strategies
in oropharyngeal candidiasis. Expert Rev Mol Med. 2008; 10:e29. https://doi.org/10.1017/
S1462399408000835 PMID: 18847522.
21. Ballou ER, Avelar GM, Childers DS, Mackie J, Bain JM, Wagener J, et al. Lactate signalling regulates
fungal beta-glucan masking and immune evasion. Nat Microbiol. 2016; 2:16238. https://doi.org/10.
1038/nmicrobiol.2016.238 PMID: 27941860.
22. Sherrington SL, Sorsby E, Mahtey N, Kumwenda P, Lenardon MD, Brown I, et al. Adaptation of Candida
albicans to environmental pH induces cell wall remodelling and enhances innate immune recognition.
PLoS Pathog. 2017; 13(5):e1006403. https://doi.org/10.1371/journal.ppat.1006403 PMID: 28542528.
23. Roselletti E, Perito S, Gabrielli E, Mencacci A, Pericolini E, Sabbatini S, et al. NLRP3 inflammasome is
a key player in human vulvovaginal disease caused by Candida albicans. Sci Rep. 2017; 7(1):17877.
https://doi.org/10.1038/s41598-017-17649-8 PMID: 29259175.
24. Hopke A, Nicke N, Hidu EE, Degani G, Popolo L, Wheeler RT. Neutrophil Attack Triggers Extracellular
Trap-Dependent Candida Cell Wall Remodeling and Altered Immune Recognition. PLoS Pathog. 2016;
12(5):e1005644. https://doi.org/10.1371/journal.ppat.1005644 PMID: 27223610.
25. Graham LM, Tsoni SV, Willment JA, Williams DL, Taylor PR, Gordon S, et al. Soluble Dectin-1 as a tool
to detect beta-glucans. J Immunol Methods. 2006; 314(1–2):164–9. https://doi.org/10.1016/j.jim.2006.
05.013 PMID: 16844139.
Fungal epitope unmasking in human vaginitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0201436 July 31, 2018 13 / 14
26. Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA. Stimulation of chitin synthesis
rescues Candida albicans from echinocandins. PLoS Pathog. 2008; 4(4):e1000040. https://doi.org/10.
1371/journal.ppat.1000040 PMID: 18389063.
27. Wood PJ. Factors affecting precipitation and spectral changes associated with complex-formation
between dyes and b-D-glucans. Carbohydrate Research. 1982; 102(1):283–93.
28. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albi-
cans yeast but not filaments. EMBO J. 2005; 24(6):1277–86. https://doi.org/10.1038/sj.emboj.7600594
PMID: 15729357.
29. Sobel JD, Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis.
J Clin Microbiol. 1996; 34(10):2497–9. PMID: 8880507.
30. Ibe C, Walker LA, Gow NAR, Munro CA. Unlocking the Threapeutic Potential of the Fungal Cell Wall:
Clinical Implications and Drug Resistance. In: Prasad R, editor. Candida albicans: Cellular and Molecu-
lar Biology: Springer, Cham; 2017.
31. Yano J, Noverr MC, Fidel PL Jr. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute
Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis. MBio. 2017; 8(2).
https://doi.org/10.1128/mBio.00211-17 PMID: 28292981.
32. Boxx GM, Kozel TR, Nishiya CT, Zhang MX. Influence of mannan and glucan on complement activation
and C3 binding by Candida albicans. Infect Immun. 2010; 78(3):1250–9. https://doi.org/10.1128/IAI.
00744-09 PMID: 20028806.
33. Swidergall M, Solis NV, Lionakis MS, Filler SG. EphA2 is an epithelial cell pattern recognition receptor
for fungal beta-glucans. Nat Microbiol. 2018; 3(1):53–61. https://doi.org/10.1038/s41564-017-0059-5
PMID: 29133884.
34. Tsoni SV, Brown GD. beta-Glucans and dectin-1. Ann N Y Acad Sci. 2008; 1143:45–60. https://doi.org/
10.1196/annals.1443.019 PMID: 19076344.
35. Usluogullari B, Gumus I, Gunduz E, Kaygusuz I, Simavli S, Acar M, et al. The role of Human Dectin-1
Y238X Gene Polymorphism in recurrent vulvovaginal candidiasis infections. Mol Biol Rep. 2014; 41
(10):6763–8. https://doi.org/10.1007/s11033-014-3562-2 PMID: 25008994.
36. Linhares IM, Summers PR, Larsen B, Giraldo PC, Witkin SS. Contemporary perspectives on vaginal pH
and lactobacilli. Am J Obstet Gynecol. 2011; 204(2):120 e1–5. https://doi.org/10.1016/j.ajog.2010.07.
010 PMID: 20832044.
37. Beghini J, Linhares IM, Giraldo PC, Ledger WJ, Witkin SS. Differential expression of lactic acid isomers,
extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from
women with vaginal disorders. BJOG. 2015; 122(12):1580–5. https://doi.org/10.1111/1471-0528.13072
PMID: 25196575.
38. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epi-
demiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998; 178(2):203–11.
PMID: 9500475.
39. Chiani P, Bromuro C, Cassone A, Torosantucci A. Anti-beta-glucan antibodies in healthy human sub-
jects. Vaccine. 2009; 27(4):513–9. https://doi.org/10.1016/j.vaccine.2008.11.030 PMID: 19041357.
Fungal epitope unmasking in human vaginitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0201436 July 31, 2018 14 / 14
